Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.

doi:10.2217/fon-2017-0019

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.

Future oncology (London, England) - 1 May 2017

Jia Zhi-Fang, Wu Yan-Hua, Cao Dong-Hui, Cao Xue-Yuan, Jiang Jing, Zhou Bao-Sen

Abstract excerpt

AIM: This study was aimed to investigate the associations between single nucleotide polymorphisms of cancer stem cell marker genes, CD44 and CD133, and susceptibility and prognosis of gastric cancer. PATIENTS & METHODS: Five single nucleotide polymorphisms in CD44 and CD133 genes were genotyped in 898 gastric cancer cases and 992 controls. RESULTS: The A/C or C/C genotypes of CD133 rs2240688 were associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Hyaluronan Receptors

Share to Neoplasm Staging

Share to Neoplastic Stem Cells

Share to Odds Ratio

Share to Prognosis

Share to Stomach Neoplasms

Source

Open in PubMed

Identifiers

PMID: 28326835
DOI: 10.2217/fon-2017-0019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.PMID 28326835Read ↗

Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.Semantic proximity Read ↗

Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancerSemantic proximity Read ↗

Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.Semantic proximity Read ↗

Polymorphisms of the stem cell marker gene CD133 are associated the clinical outcome in a cohort of Chinese non-small cell lung cancer patients.Semantic proximity Read ↗

Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profilingSemantic proximity Read ↗

Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44Semantic proximity Read ↗

Genetic variations in stem cell-related genes and colorectal cancer prognosis.Semantic proximity Read ↗

Common polymorphisms in CD44 gene and susceptibility to cancer: A systematic review and meta-analysis of 45 studies.Semantic proximity Read ↗

Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations.Semantic proximity Read ↗

Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population.Semantic proximity Read ↗

Quantitative assessment of CD44 genetic variants and cancer susceptibility in Asians: a meta-analysis.Semantic proximity Read ↗

The Contribution of CD133 Gene Polymorphisms to Cancer Risk: Integrating Case-Control Evidence With Meta-Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.